Constellation Brands Inc. (NYSE: STZ) reported second-quarter fiscal 2014 adjusted diluted earnings per share (EPS) of $0.96 on revenue of $1.46 billion. In the same period a year ago, the premium wine and beverage company reported adjusted diluted EPS of $0.50 on revenue of $698.5 million. Second-quarter results also compare to the Thomson Reuters consensus estimates for EPS of $0.88 and $1.53 billion in revenue.
On a GAAP basis, EPS totaled $7.74, which includes a $1.6 billion noncash gain on the revaluation of its original 50% stake in Mexican brewer Crown Imports. In June Constellation completed its $4.75 billion acquisition of the 50% of Crown it did not already own. Net income for the quarter on a comparable basis totaled $189 million; including the brewing company acquisition, net income totaled $1.522 billion.
Constellation’s adjusted EPS guidance for the 2014 fiscal year now stands at a range of $2.80 to $3.10, well above the $2.19 EPS for fiscal 2013. The consensus estimate from analysts calls for EPS of $2.83. On a GAAP basis, the company expects to post EPS of $9.30 to $9.60.
Hot Safest Companies To Invest In 2014: SofTech Inc (SOFT)
SofTech, Inc., incorporated on June 11, 1969,is a provider of engineering software solutions with its ProductCenter PLM (product lifecycle management) technology and its computer-aided design product CADRA offering. On May 24, 2011, the Company sold its Advanced Manufacturing Technology (AMT) product line. In October 2013, SofTech, Inc announced that it has completed the sale of substantially all of the assets of its CADRA product line.
The Company’s ProductCenter technology manages the engineering data and electronic files of discrete parts designed in third party design technologies offered primarily by Solidworks, Parametric Technology Corporation (PTC) and Autodesk. ProductCenter is an enterprise, collaborative PLM solution delivering a combination of document management, design integration, configuration control, change management, bill of materials management and integration capability with other enterprise systems. ProductCent er is designed to help companies optimize the product development process. ProductCenter provides for the secure management of product information and allows engineers and the entire design chain to manage, share, modify and track product data and documents throughout the product development lifecycle.
The Company’s ProductCenter supports engineering change management and bill of materials management for automating business processes. ProductCenter also enables integration with other business applications, such as enterprise resource planning (ERP), supply chain management (SCM) and customer relationship management (CRM) for continuous data exchange across the product lifecycle.
The Company’s CADRA offering is a drafting and design software package for the professional mechanical engineer. The CADRA family of CAD/CAM products includes CADRA Design Drafting, a mechanical design documentation tool, CADRA NC, a 2 through 5 axis NC programming application, and CADRAWorks with SolidWorks p! roviding for an integrated drawing production system and three dimensional (3D)solid modeler. The CADRA family of products includes a collection of translators and software options.
The Company competes with Autodesk, Dassault, Siemens, and PTC
- [By Peter Graham]
Small cap stocks New China Global (OTCMKTS: NCGI), RealBiz Media Group Inc (OTCMKTS: RBIZ) and SofTech, Inc (OTCMKTS: SOFT) sank 21.11%, 14.81% and 10.89%, respectively, last Friday. Moreover, two of these three small caps have been the subject of paid promotions or investor relations activities, but this week is the start of a new trading week and anything can happen. So will these three small cap stocks keep sinking? Here is a closer look to help you decide on an investing or trading strategy:
- [By Peter Graham]
Small cap tech, mobile or cloud computing stocks SofTech, Inc (OTCMKTS: SOFT), Firstin Wireless Technology Inc (OTCMKTS: FINW) and Izea Inc (OTCMKTS: IZEA) have been getting some extra attention lately in various investment newsletters or alerts. That’s because at least one of these stocks appears to be the subject of paid third party promotions while another is the focus of an apparent investor relations campaign. Keeping that in mind, are these three tech orientated stocks going to bring profits to investors and traders or bring out the luddite in them? Here is a closer look:
Hot Safest Companies To Invest In 2014: pSivida Corp.(PSDV)
pSivida Corp., together with its subsidiaries, develops drug delivery products for treatment of back-of-the-eye diseases that are administered by implantation, injection, or insertion. The company?s lead product candidate includes Iluvien, which is in Phase III clinical trials and delivers fluocinolone acetonide (FA) for the treatment of diabetic macular edema (DME), a cause of vision loss. It is also conducting Phase II clinical trials with Iluvien for the treatment of wet and dry form of age-related macular degeneration, and retinal vein occlusion. In addition, the company?s products include Retisert for the treatment of posterior uveitis, an autoimmune condition characterized by inflammation of the posterior of the eye that can cause sudden or gradual vision loss; and Vitrasert for cytomegalovirus retinitis, a blinding eye disease that occurs in individuals with advanced AIDS. It is developing the Latanoprost product, an injectable, bioerodible drug delivery implant i n Phase I/II dose-escalating study for the treatment of glaucoma and ocular hypertension; the Posterior Uveitis product candidate in a Phase I/II study for the treatment of posterior uveitis; BioSilicon technology system, which is nano-structured porous silicon designed for use as a drug delivery platform and to deliver smaller molecules; and Tethadur, which utilizes BioSilicon to deliver large biologic molecules, including peptides and proteins. It has strategic collaborations with Bausch & Lomb Incorporated; Alimera Sciences, Inc.; Pfizer, Inc.; and Intrinsiq Materials Cayman Limited. The company was founded in 1987 and is headquartered in Watertown, Massachusetts.
- [By Smith On Stocks]
This note focuses on the implications of the complete response letter (CRL) received by Alimera (ALIM) for Iluvien. This product was developed by pSivida (PSDV) but was partnered with Alimera. This report deals only with the investment significance for pSivida.
- [By John Kell]
Specialty pharmaceutical firm pSivida Corp.(PSDV) said the U.S. Food and Drug Administration didn’t approve a treatment for an eye disease found in patients with diabetes. The company’s stock tumbled 47% to $2 premarket, while shares of Alimera Sciences Inc.(ALIM) were down 39% to $1.66, as the treatment is licensed and sold by Alimera in other markets.
Hot Safest Companies To Invest In 2014: Seabridge Gold Inc (SA)
Seabridge Gold Inc. (Seabridge) is a development-stage company. The Company is engaged in the acquisition and exploration of gold properties located in North America. As of December 31, 2011, the Company held six properties with gold resources and its material properties are its KSM Project and its Courageous Lake Project. The Company holds a 100% interest in each of its properties. Its projects include KSM (Kerr-Sulphurets-Mitchell), Courageous Lake, Pacific Intermountain Gold, Grassy Mountain, Red Mountain, Quartz Mountain, Castle Black Rock and Other Nevada projects. The KSM project consists of two contiguous claim blocks in the Iskut-Stikine region in British Columbia, approximately 20 kilometers southeast of the Eskay Creek Mine. The Courageous Lake project is a gold project covering approximately 81,700 acres located in the Northwest Territories, Canada. Advisors’ Opinion:
- [By Lisa Levin]
Gold: This industry rose 1.44% by 10:40 am ET. The top performer in this industry was Seabridge Gold (NYSE: SA), which gained 11.3%. Seabridge Gold shares have dropped 60.24% over the past 52 weeks, while the S&P 500 index has gained 26.39% in the same period.
- [By Selena Maranjian]
Seabridge Gold (NYSE: SA ) also lost 50%. Some of its operations in Canada have been yielding high-grade materials, and its KSM Gold project in British Columbia “contains one of the largest undeveloped gold and copper reserves in the world.” The company’s strategy explicitly includes trying to avoid share dilution. Like many of its peers, though, it’s still operating in the red, so tread carefully.
Hot Safest Companies To Invest In 2014: QR Energy LP(QRE)
QR Energy, LP, through its subsidiary, QRE Operating, LLC, engages in the acquisition, production, and development of onshore crude oil and natural gas properties in the United States. As of March 31, 2011, its properties consisted of working interests in 2,140 gross producing wells located in Alabama, Arkansas, Kansas, Louisiana, New Mexico, Oklahoma, and Texas. QRE GP, LLC operates as the general partner of the company. QR Energy, LP was founded in 2006 and is based in Houston, Texas.
- [By Robert Rapier]
While I still think LRE units are undervalued, BreitBurn Energy Partners probably presents a more compelling case at present.
QR Energy (NYSE: QRE) reported a solid third quarter, with earnings before interest, taxation, depreciation and amortization (EBITDA) up 13 percent to $69 million. Production was up 5 percent despite a disruption at some of it operations.
Distributable cash flow for the quarter was up 26 percent to $35 million, or $0.54 per unit, adequately covering its current distribution of $0.4875. (The partnership will convert to monthly distributions in 2014.) Based on Friday’s close, this translates into an annualized yield of 11.8 percent. Given that QRE’s solid performance came despite temporary production issues, it looks like a decent bet in the upstream MLP space for 2014.
- [By Aimee Duffy]
3. QR Energy (NYSE: QRE ) — 11.7% yield
QR Energy is an exploration and production MLP, focused on developing mature assets in five different oil- and gas-producing regions stretching from the Permian Basin up to central Michigan. It’s a small operation, with reserves of 99.1 million barrels of oil equivalent to its name.
Hot Safest Companies To Invest In 2014: Walter Bau AG (WTB)
Walter Bau AG is an international construction group based in Augsburg, southern Germany. The Company’s core construction-related services are planning, financing, project development and facilities management. It is active in the fields of turnkey construction, civil engineering, international construction and transportation infrastructure. Its subsidiary, DYWIDAG-Systems International markets the Company’s products and systems worldwide, particularly in the field of post-tensioning and geotechnics, as well as special civil engineering processes. Walter Bau also provides operation and financing solutions, as well as developing commercial and residential real estate projects. Facilities Management is offered by DYWIDAG Service GmbH. Its Logistics Competence Center in Augsburg bundles the Company’s Germany-wide activities as a general contractor in the planning, construction and support of distribution centers. The Company commenced insolvency proceedings in April 2005. Advisors’ Opinion:
- [By Sofia Horta e Costa]
Whitbread Plc (WTB) added 4.1 percent to 3,114 pence, its largest advance since September 2012. Oriel Securities Ltd. raised its rating on the shares to buy from hold, citing improvement in the U.K. hotel market.
- [By Namitha Jagadeesh]
BHP Billiton Ltd. (BHP) and Rio Tinto Group, the world’s biggest mining companies, fell at least 3 percent. Whitbread Plc (WTB) dropped 2.8 percent after UBS AG downgraded the owner of the Costa Coffee chain. British Land Co., the U.K.’s second-largest real estate investment trust, advanced 1.2 percent after saying it bought commercial property in London for 470 million pounds ($707 million).
Hot Safest Companies To Invest In 2014: Alon USA Partners LP (ALDW)
Alon USA Partners, LP (Alon USA), incorporated on August 17, 2012, owns and operates refining and petroleum products marketing business. Its integrated downstream business operates primarily in the South Central and Southwestern regions of the United States. It owns and operates a crude oil refinery in Big Spring, Texas with total throughput capacity of approximately 70,000 barrels per day (bpd). The crude oil pipelines the Company utilizes consist of the Amdel, White Oil, Mesa Interconnect, Centurion and Centurion Interconnect. Its Big Spring refinery produces ultra-low sulfur gasoline, ultra-low sulfur diesel, jet fuel, petrochemicals, petrochemical feedstocks, asphalt and other petroleum products.
During the year ended December 31, 2011 and the six months ended June 30, 2012, sour crude, such as West Texas Sour (WTS), represented approximately 80.4% and 80.4% of its throughput, respectively, and sweet crude, such as West Texas Intermediate (WTI), represente d approximately 15.8% and 17.1% of its throughput, respectively. For the year ended December 31, 2011 and the six months ended June 30, 2012, the Company produced approximately 49.1% and 49.2% gasoline, 32.3% and 32.5% diesel/jet fuel, 7.1% and 6.4% asphalt, 6.0% and 6.0% petrochemicals and 5.5% and 5.9% other refined products, in each case, respectively. The Company distributes fuel products through a product pipeline and terminal network of seven pipelines totaling approximately 840 miles and six terminals that it owns or access.
The Company competes with Chevron, ExxonMobil and Shell.
- [By Robert Rapier]
I warned last week that refiners would report relatively poor earnings for Q3, and refinery MLPs could take a hit, presenting a buying opportunity. On Nov. 6 Alon USA Partners (NYSE: ALDW) reported a loss for the third quarter of $16.1 million, or ($0.26) per unit, compared with net income of $120.4 million for the same period last year. Paul Eisman, CEO and president, cited the deteriorating margins that I discussed in last week’s issue: “Our third quarter results were impacted by a volatile and deteriorating margin environment resulting primarily from decreasing discounts for West Texas crude oil.”
- [By Robert Rapier] In last week’s issue I discussed the basics of the refining sector. Today I will provide an overview of four MLPs that hold refining assets.
To review, the refining sector was very profitable in 2012 thanks to unusually high crack spreads, which for many US refiners are approximated by the price differential between Brent and West Texas Intermediate (WTI) crude oils. For a more thorough explanation of this phenomenon, please refer to last week’s issue.
After years of trading at a $1 to $3 per barrel discount to WTI, Brent began fetching a premium a few years ago as a glut of crude developed in the mid-continent area of the US. In 2011 the Brent-WTI price differential increased to more than $25/bbl, and it remained historically high in 2012.
But pipeline capacity started to catch up this year, and the share prices of refiners retreated as the glut began to dissipate and the Brent-WTI differential shrank. In Q3 2012, the Brent-WTI differential a veraged $17.43/bbl, but by Q3 of this year, the differential had fallen to $4.43/bbl. This promises bad news for refiners about to report Q3 earnings.
Many analysts downgraded the refining sector in Q3, but as the differential fell below $5/bbl it was hard to imagine that the news could get much worse. With poor Q3 results largely priced in, the differential subsequently rose back above $10/bbl, signaling better refining margins moving into Q4.
Refiners began to post earnings this past week, and as expected they were weak. Valero (NYSE: VLO) reported slightly higher revenues year-over-year, but net earnings fell more than 50 percent from a year ago. Nevertheless, they beat the extremely pessimistic expectations of analysts, and Valero shares rose on the news.
Phillips 66’s (NYSE: PSX) refining unit actually posted a loss, but its chemical business turned in a solid quarter which more than compensated for the disappointing refining results.
T he rest of the refine
- [By Rick Munarriz]
Alon Partners USA (NYSE: ALDW ) reports on Wednesday. Analysts see the oil refiner earning $1.36 per unit on Wednesday, and that’s welcome news for investors. Alon Partners is set up as a limited partnership, passing on most of the money it makes to its stakeholders.
Hot Safest Companies To Invest In 2014: Cubist Pharmaceuticals Inc.(CBST)
Cubist Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment. The company markets CUBICIN (daptomycin for injection), a once-daily, bactericidal, intravenous, antibiotic with activity against gram-positive organisms, including methicillin-resistant staphylococcus aureus. Its clinical development product pipeline consists of CXA-201, which is in the phase III clinical trial for patients with complicated urinary tract infections; and in phase II clinical trial for patients with complicated abdominal infections. The company is also developing CXA-201 for the treatment of hospital acquired pneumonia. In addition, its product under development comprises CB-183,315, an oral, bactericidal lipopeptide with in vitro bactericidal activity against C. difficile, for the treatment of clostridium difficile-associated diarrhea (CDAD). Further , the company?s pre-clinical programs include therapies to treat various bacterial infections and agents to treat acute pain. Additionally, it promotes MERREM I.V. (meropenem for injection), a carbapenem class intravenous antibiotic, in the United States under a commercial services agreement with AstraZeneca Pharmaceuticals, LP; and DIFICID as the treatment for CDAD in adults under the co-promotion agreement with Optimer Pharmaceuticals, Inc. The company also has collaborations with Forma Therapeutics, Inc. to discover and develop antibacterial compounds; an agreement with the Broad Institute to transform natural products discovery; a collaboration with Hydra Biosciences, Inc., to develop ion channel drugs; and a collaboration agreement with Alnylam Pharmaceuticals, Inc., for the development and commercialization of Alnylam’s RNAi therapeutics as a therapy for the treatment of respiratory syncytial virus. The company was founded in 1992 and is headquartered in Lexington, Ma s sachusetts.
- [By Sean Williams]
What: Shares of Cubist Pharmaceuticals (NASDAQ: CBST ) , a biopharmaceutical company devoted to developing acute care therapies, added 12% following the announcement of its second-quarter earnings results.
- [By Jake Keator]
Shares of Cubist Pharmaceuticals (NASDAQ: CBST ) exploded upward on Friday, finishing up over 9%. The company reported strong second-quarter results Thursday, beating average analyst estimates for both revenue and EPS. Total net revenues were $258.8 million, up 12.2% over Q2 2012, while non-GAAP diluted EPS was $0.42. Average analyst estimates were $254.73 million for revenue and EPS of $0.38.
- [By Rich Bieglmeier]
Cubist Pharmaceuticals Inc. (CBST) share price is the beneficiary of an upgrade yesterday. Leerink Swann analyst Marko Kozul believes the biotech is headed to $76.